| Smi | 6348.07 | |
| Abb N | 20.35 | |
| Actelion N | 45.35 | |
| Adecco N | 48.99 | |
| Cs Group N | 44.95 | |
| Holcim N | 64.10 | |
| Julius Baer Grp N | 37.56 | |
| Lonza Grp N | 87.90 | |
| Nestle N | 53.80 | |
| Novartis N | 54.15 | |
| Richemont | 41.81 | |
| Roche Hldg Dr | 143.30 | |
| The Swatch Grp | 337.10 | |
| Sgs Reg | 1527.00 | |
| Swiss Re N | 43.18 | |
| Transocean N | 53.70 | |
| Swisscom Reg | 397.60 | |
| Syngenta N 2l | 245.00 | |
| Synthes | 118.80 | |
| Ubs N | 17.52 | |
| Zurich Finl Svcs | 232.60 | |
| Hecla Mining Comp | 5.94 | |
| Goldman Sachs Gro | 145.21 | |
| Citigroup, Inc. C | 3.83 | |
| Apple Inc. | 257.81 | |
| Noble Corporation | 33.80 |
The movement of a security's price over a specific time period.
dedicated to value creation and applying the scientific method in finance
network network - market statistics network - archived market statistics High dividend yield stocks
- dynamic hedging, Portfoliooptimierung, quantitatives research
- Kreditderivate, CDS, CDO, CLN
- dynamic hedging
« Baloise nominiert Michael Becker fuer Wahl in den Verwaltungsrat | Main | GAM nominiert Diego du Monceau fuer die Wahl in den Verwaltungsrat »
By admin | March 12, 2010
Topics: Roche | No Comments »
Trackback URL for this post: http://www.tradingpattern.ch/2010/03/12/roche-verfehlt-mit-avastin-primaeren-endpunkt-bei-prostatakrebs/trackback/
You must be logged in to post a comment.